Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Optical Mammography: Imaging breast cancer response to neoadjuvant chemotherapy

Not Accessible

Your library or personal account may give you access


Optical mammograms were obtained on 7 patients undergoing neoadjuvant chemotherapy. When therapy was 30% complete, patients achieving a high pathologic response had a lower oxy-hemoglobin decrease compared to those with extensive disease remaining.

© 2016 Optical Society of America

PDF Article
More Like This
Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Using Dynamic Tomographic Optical Breast imaging (DTOBI)

Amir Y. Sajjadi, Steven J. Isakoff, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
BW4B.5 Biomedical Optics (BIOMED) 2014

Pretreatment Prediction of Neoadjuvant Chemotherapy Response in HER-2 Positive Breast Cancer Patients Using Diffuse Optical Tomography Imaging

Mirella L. Altoe, Alessandro Marone, Hyun K. Kim, Mariella Tejada, Hanina Hibshoosh, Hua Guo, Katherine D. Crew, Melissa K. Accordino, Meghna Trivedi, Kevin Kalinsky, Dawn L. Hershman, and Andreas H. Hielscher
SM2D.2 Optical Tomography and Spectroscopy (OTS) 2020

Pre-treatment total hemoglobin in breast cancer is a predictor for complete response to neoadjuvant chemotherapy

Shudong Jiang, Brian W. Pogue, Jiang Gui, Michael Jermyn, Peter Kaufman, and Keith D. Paulsen
BW4B.2 Biomedical Optics (BIOMED) 2014


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access Optica Member Subscription

Select as filters

Select Topics Cancel
© Copyright 2022 | Optica Publishing Group. All Rights Reserved